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ABSTRACT
Introduction. Recognition and visual working memory tasks from the Wechsler Memory
Scale–Fourth Edition (WMS–IV) have previously been documented as useful indicators
for suboptimal performance. The present study examined the clinical utility of the
Dutch version of the WMS–IV (WMS–IV–NL) for the identification of suboptimal perfor-
mance using an analogue study design.
Method. The patient group consisted of 59 mixed-etiology patients; the experimental
malingerers were 50 healthy individuals who were asked to simulate cognitive impair-
ment as a result of a traumatic brain injury; the last group consisted of 50 healthy
controls who were instructed to put forth full effort.
Results. Experimental malingerers performed significantly lower on all WMS–IV–NL tasks
than did the patients and healthy controls. A binary logistic regression analysis was
performed on the experimental malingerers and the patients. The first model contained
the visual working memory subtests (Spatial Addition and Symbol Span) and the
recognition tasks of the following subtests: Logical Memory, Verbal Paired Associates,
Designs, Visual Reproduction. The results showed an overall classification rate of 78.4%,
and only Spatial Addition explained a significant amount of variation (p < .001).
Subsequent logistic regression analysis and receiver operating characteristic (ROC)
analysis supported the discriminatory power of the subtest Spatial Addition. A scaled
score cutoff of <4 produced 93% specificity and 52% sensitivity for detection of
suboptimal performance.
Conclusion. The WMS–IV–NL Spatial Addition subtest may provide clinically useful
information for the detection of suboptimal performance.
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Assessment of memory functioning plays a key
role in neuropsychological evaluation of patients
with a variety of neurological and psychiatric dis-
orders. There are several well-developed and stan-
dardized memory tests and batteries available, such
as the Wechsler Memory Scale (WMS; Lezak,
Howieson, Bigler, & Tranel, 2012). However, one
of the difficulties that arise when validating neu-
ropsychological tests is the assumption that the test
performance of the examinee is a true reflection of
his or her actual level of ability (Brennan &
Gouvier, 2006; Larrabee, 2012; Merckelbach,
Smeets, & Jelicic, 2009; Slick, Sherman, &
Iverson, 1999). Therefore, it is recommended to
assess performance validity routinely in neuropsy-
chological evaluations (American Academy of
Clinical Neuropsychology, 2007; Bush et al., 2005;
Heilbronner et al., 2009).
One possible cause for invalid test perfor-
mance is malingering, which is defined as “the
intentional production of false or grossly exag-
gerated physical or psychological problems.
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Motivation for malingering is usually external
(e.g., avoiding military duty or work, obtaining
financial compensation, evading criminal prose-
cution, or obtaining drugs)” (Diagnostic and sta-
tistical manual of mental disorders–Fifth Edition,
DSM–V; American Psychiatric Association,
2013). There are several performance validity
tests (PVTs) that are designed with the purpose
of assessing whether an individual’s test perfor-
mance on data obtained by neuropsychological
tests is valid (Dandachi-FitzGerald, Ponds, &
Merten, 2013; Larrabee, 2012). Examples of
PVTs are the Test of Memory Malingering
(TOMM; Tombaugh, 1996) and the Amsterdam
Short Term Memory Test (ASTM: Schmand,
Lindeboom, & Merten, 2005; Schagen,
Schmand, de Sterke, & Lindeboom, 1997).
In addition to PVTs, several studies have pro-
posed methodologies to derive indicators of sub-
optimal performance within common
neuropsychological tests, so called “embedded”
validity indicators (Larrabee, 2012; Slick et al.,
1999). Well-established embedded indicators for
suboptimal performance are poor performance on
recognition tasks in relation to relatively adequate
performance on delayed recall tasks (Bernard,
1990; Haines & Norris, 2001; Langeluddecke &
Lucas, 2003) and relatively poor performance on
tasks involving immediate span of attention, as
they may be perceived as memory tasks by mal-
ingerers while tapping simple attentional functions
(Axelrod, Fichtenberg, Millis, & Wertheimer, 2006;
Heinly, Greve, Bianchini, Love, & Brennan, 2005;
Iverson & Tulsky, 2003; Langeluddecke & Lucas,
2003).
In particular, memory tests have been exam-
ined to determine their efficacy in identifying
suboptimal performance (cf. Lu, Rogers, &
Boone, 2007; Suhr & Barrash, 2007), mainly
because tests designed to assess memory and con-
centration are particularly susceptible to exag-
geration or fabrication of cognitive impairment.
This is hardly surprising given that it is well
known that memory and concentration disorders
are common symptoms following head injury
(Mittenberg, Azrin, Millsaps, & Heilbronner,
1993; Williams, 1998). Several studies have exam-
ined indicators and patterns of suboptimal per-
formance using the Wechsler Memory Scale–
Third Edition (WMS–III; Wechsler, 1997), with
varying levels of success. Some of these studies
have used the entire instrument and
demonstrated that malingering traumatic brain
injury (TBI) patients returned lower WMS–III
mean scores than nonmalingering TBI patients
(Langeluddecke & Lucas, 2003; Ord, Greve, &
Bianchini, 2008). Other studies have examined
the use of specific subtests (Faces; Glassmire
et al., 2003), rarely missed items (Rarely Missed
Index; Bortnik et al., 2010; Killgore & DellaPietra,
2000; Lange, Sullivan, & Anderson, 2005; L. J.
Miller, Ryan, Carruthers, & Cluff, 2004; Swihart,
Harris, & Hatcher, 2008), and difference-scores
for index and subtests (Lange, Iverson, Sullivan,
& Anderson, 2006; Langeluddecke & Lucas, 2003)
to discriminate between malingering and nonma-
lingering patients.
For the latest editions of the Wechsler intelli-
gence and memory batteries, the Wechsler Adult
Intelligence Scale–Fourth Edition (WAIS–IV;
Wechsler, 2008) and the Wechsler Memory
Scale–Fourth Edition (WMS–IV; Wechsler, 2009),
the additional Advanced Clinical Solutions (ACS)
package provides several embedded measures for
the detection of malingering including the Reliable
Digit Span from the WAIS–IV (Greiffenstein,
Baker, & Gola, 1994), the four recognition tasks
(Logical Memory Recognition, LM-Rec; Verbal
Paired Associates Recognition, VPA-Rec; Visual
Reproduction Recognition, VR-Rec; and Designs
Recognition, DE-Rec) from the WMS–IV, and
the newly developed Word Choice Test (which
has a similar format to that of the Warrington
Memory Test; Holdnack & Drozdick, 2009).
So far, only two studies found promising results for
the WMS–IV ACS package as an effective tool
for detection of suboptimal performance (Holdnack
& Drozdick, 2009; J. B. Miller et al., 2011).
Furthermore, a recent study by Young, Caron,
Baughman, and Sawyer (2012) identified the Symbol
Span subtest as an indicator of suboptimal perfor-
mance. This is not surprising as the Symbol Span is
a visual analogue of the Digit Span task, which has
proven to be able to detect malingering according to a
number of validation studies (Axelrod et al., 2006;
Babikian, Boone, Lu, & Arnold, 2006; Heinly et al.,
2005; Iverson & Tulsky, 2003).
The WMS is one of the most widely used mem-
ory batteries to assess memory function (Rabin,
Barr, & Burton, 2005). Several studies have
reported effective embedded validity indicators
using previous versions of the WMS, but so far
only few studies used the WMS–IV. The aim of
our study is to examine whether several tasks of
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the WMS–IV can be used as embedded validity
indicators using the Dutch version of this battery
(WMS–IV–NL; Hendriks, Bouman, Kessels, &
Aldenkamp, 2014). We selected a number of
tasks that we expected to distinguish between mal-
ingering participants and nonmalingering neurolo-
gical patients. First, we selected the visual working
memory tasks Spatial Addition (SA) and Symbol
Span (SSP), as working memory tests were pre-
viously found to be sensitive in other WMS studies
(Lange et al., 2006; Young et al., 2012). Secondly,
we selected the recognition tasks LM-Rec, VPA-
Rec, DE-Rec, and VR-Rec, because these subtests
were already shown to be sensitive in previous
research using the WMS–IV (Holdnack &
Drozdick, 2009; J. B. Miller et al., 2011).
Method
Participants
A three-group design was used to compare
WMS–IV–NL performance of healthy volunteers
who were instructed to simulate cognitive
impairment due to TBI (i.e., “experimental mal-
ingerers”), mixed-etiology patients, and healthy
controls. The first sample of experimental mal-
ingerers consisted of 50 healthy participants who
were instructed to pretend to be cognitively
impaired as a result of a TBI. This group of
participants was recruited by the researchers
through their network. Exclusion criteria for
this sample were: inability to speak/understand
the Dutch language; significant hearing or visual
impairment; psychiatric or neurologic disorder;
substance abuse affecting cognitive functioning;
use of medicines affecting cognitive functioning;
and not following the malingering instruction, as
established by a questionnaire and a PVT: the
ASTM (see also Procedure section).
Second, a total of 59 mixed-etiology patients
were recruited from several rehabilitation centres
in the Netherlands: Bavo-Europoort Center for
Neuropsychiatry/Acquired Brain Injury,
Rotterdam (n = 21); Bravis Hospital Roosendaal
(n = 20); Rehabilitation Centre Groot
Klimmendaal Arnhem (n = 14); and Sophia
Rehabilitation Centre, The Hague (n = 4). Of
these patients, 27 were diagnosed with TBI; 23
with a stroke (cerebrovascular accident; CVA); 4
with postanoxic encephalopathy; 2 with a tumor;
2 with multiple sclerosis; and 1 with
meningococcal meningitis. Patients were
excluded if they met the following exclusion
criteria: inability to speak/understand the Dutch
language; significant hearing or visual impair-
ment; evidence for suboptimal performance
(based on performance validity testing or expert
opinion).
The third sample of participants consisted of 50
healthy controls selected from the Dutch version of
the WMS–IV (WMS–IV–NL) standardization
study (see Hendriks et al., 2014, for a detailed
description of the participant selection) and were
matched for age, sex, and education level with the
other groups. Moreover, healthy controls were
excluded if they met the following exclusion cri-
teria: inability to speak/understand the Dutch lan-
guage; significant hearing or visual impairment;
psychiatric or neurologic disorder; substance
abuse affecting cognitive functioning; and use of
medicines affecting cognitive functioning.
Participant characteristics are summarized in
Table 1.
Measures
The primary measure in this study was the WMS–
IV–NL, which was administered and scored accord-
ing to the test manual (Hendriks et al., 2014). The
authorized Dutch version of the WMS–IV is
equivalent to the original American version. The
nonverbal visual stimuli are identical in both lan-
guage versions, and the instruction, auditory sti-
muli, and scoring criteria were translated and
adapted to the Dutch language. A previous study
revealed that the WMS–IV and WMS–IV–NL have
a similar factor structure (Bouman, Hendriks,
Kerkmeer, Kessels, & Aldenkamp, 2015).
The WMS–IV–NL contains one optional subt-
est, the Brief Cognitive Status Exam (BCSE), and
six primary subtests: Logical Memory (LM), Verbal
Paired Associates (VPA), Designs (DE), Visual
Reproduction (VR), Spatial Addition (SA) and
Symbol Span (SSP). Of these, four subtests (LM,
VPA, DE, and VR) have immediate and delayed
recall conditions. The primary subtests were con-
verted into age-adjusted scaled scores (M = 10, SD
= 3), which were used in all analyses. These subtest
scaled scores can be used to calculate five index
scores: Auditory Memory Index (AMI), Visual
Memory Index (VMI), Immediate Memory Index
(IMI), Delayed Memory Index (DMI) and Visual
Working Memory Index (VWMI). Several subtests
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also include optional tasks, including recognition
tasks (for the subtests LM, VPA, DE and VR),
separate scores for DE content and spatial scores,
a word recall task for VPA (in which the examinee
is asked to sum up as many of the words from the
pairs as he or she can recall), and a copy task for
VR (in which the examinee is asked to draw the
figures while looking at them). Because the score
distribution of the recognition tasks and the VR
copy task are highly skewed, there are no scaled
scores available in the WMS–IV. Thus, in the
following analyses raw scores were used for these
tasks.
In addition, the Dutch version of the National
Adult Reading Test (NART: Nelson, 1982;
DART: Schmand, Lindeboom, & Van
Harskamp, 1992) was administered to all partici-
pants to obtain an estimation of premorbid ver-
bal intelligence. Moreover, the experimental
malingerers underwent short structured inter-
views at the beginning and the end of the exam-
ination and completed the ASTM (Schagen et al.,
1997; Schmand et al., 2005). The ASTM is a
forced-choice verbal memory test that is designed
to assess (in)valid performance. Individual per-
formance on the ASTM was used to perform a
manipulation check (i.e., to check whether a
experimental malingerer performed below the
previously established cutoff score of ≤84). With
a cutoff score of ≤84 the ASTM has a sensitivity
of 91% and a specificity of 89% (Schmand et al.,
2005). Also, two questionnaires were used to
determine how they interpreted the complaints
accompanying TBI (for the detailed question-
naires see the Appendix).
Procedure
This study was approved by the Institutional Review
Board of the Faculty of Social Sciences of Radboud
University in Nijmegen, and patient data were col-
lected as part of the routine clinical assessment of
each participating centre. Written informed consent
was obtained from all participants.
The examiner provided the participants in the
experimental malingering group with the following
scenario and instructions containing symptom
coaching two days before testing. This scenario was
based on previous studies (Brennan & Gouvier,
2006; Brennan et al., 2009; Suhr & Gunstad, 2000;
Tan, Slick, Strauss, & Hultsch, 2002; Weinborn,
Woods, Nulsen, & Leighton, 2012) and the recom-
mendations outlined by Suhr and Gunstad (2000).
Instructions: Six months ago you were involved
in a car accident, and you don’t suffer any con-
sequences from it at the moment. Imagine that
your lawyer tells you that you could get a large
sum of money from an insurance company, but
only if it is determined that you suffer from
brain damage. In a few days, you will undergo
neuropsychological tests to assess whether you
have brain damage. You have decided to simu-
late the symptoms of brain damage. Commonly
experienced problems in brain damage are: fati-
gue, memory problems and problems with
attention, depression, slowed response, irritabil-
ity and anxiety. Try to imagine how a person
with brain damage would perform on these tests
you’re about to take. Do keep in mind that you
have to make it seem believable; some of the
tests you will take can be specifically designed to
detect people faking. When the results of the
assessment show that you have been faking,
you will not get the money. If you think it is
necessary you may look for information about
brain damage to prepare yourself. You cannot
ask the test assessor any questions about your
role though.
This scenario was successfully used in prior
research as an example of extrinsic motivation to
malinger (Brennan & Gouvier, 2006; Jelicic,
Merckelbach, Candel, & Geraerts, 2007).
Furthermore, the described TBI symptoms were
Table 1. Participant characteristics.
Experimental malingerers Mixed-etiology patients Controls Statistic p
N 50 59 50
Age (years; mean, SD) 40.6 (14.7) 46.1 (16.3) 40.3 (14.6) F(2, 156) = 2.57 .083
Sex distribution (M/F) 28/22 40/19 28/22 χ2(2, n= 159) = 2.16 .340
Education level (low/average/high) 15/21/14 26/18/12 16/21/13 χ2(2, n= 159) = 3.05 .218
DART IQ (mean, SD) 102.3 (13.7) 94.8 (14.4) 101.8 (15.4) F(2, 149) = 4.33 .015
Note. Education level was assessed by classifying formal schooling in the Netherlands according to the grouping of the Central Office of Statistics
for the Netherlands (CBS, 2011), which is based on the International Standard Classification of Education (ISCED: United Nations Educational,
Scientific and Cultural Organisation Institute for Statistics UNESCO-UIS, 2011). The National Adult Reading Test (NART) IQ was not available from
all patients. DART = Dutch version of NART; M = male; F = female. The sample size: experimental malingerers, n = 50; mixed-etiology patients,
n = 54; and healthy controls, n = 48.
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likely to be found online or to be provided by a
client’s lawyer in a real litigation case. If a partici-
pant was unable or unwilling to follow the instruc-
tions, he or she was excluded from the study.
Prior to testing, all experimental malingerers
underwent a structured interview about their
complaints to simulate a true neuropsychological
assessment. Following the completion of the neu-
ropsychological tests according to the standar-
dized procedures—ASTM, WMS–IV–NL—the
experimental malingerers completed a question-
naire requiring them to report whether or not
they followed instructions to feign cognitive
impairment (for the detailed questionnaires see
the Appendix). Finally, the experimental malin-
gerers were asked to put forth their full effort on
the DART.
For the patients, the WMS–IV–NL and DART
were administered as part of a comprehensive neu-
ropsychological evaluation; for the healthy controls,
the WMS–IV–NL and DART were administered as
part of the Dutch standardization study (Hendriks
et al., 2014). All these participants were asked to
put forth their full effort on all (neuro)psychological
tests.
Analyses
First, we compared the three groups (experimental
malingerers, mixed-etiology patients, and healthy
controls) using a one-way multivariate analyses of
variance (MANOVA) with group (experimental
malingerers, patients, healthy controls) as
between-subjects factor and 15 WMS–IV–NL subt-
est scores as dependent variables. Furthermore, as
the WMS–IV–NL BCSE and subtest recognition
scores were not normally distributed, Kruskall–
Wallis analyses were carried out. Significant differ-
ences were analyzed with Bonferroni-corrected
post hoc analyses.
Group means of overall performance reveal lit-
tle information about the test’s ability to detect
suboptimal performance, and, therefore, we also
performed logistic regression analyses. As the
working memory and recognition subtests are
expected to indicate malingering based on previous
research and theoretical background, we used these
six scores in a logistic regression analysis (SA, SSP,
LM II Rec, VPA II Rec, DE II Rec, and VR II Rec).
Only experimental malingerers and patients were
included, as the differentiation between these two
groups was of interest here. If a selection of WMS–
IV–NL score(s) were found to contribute substan-
tially to the model’s ability to predict outcome, a
subsequent logistic regression analysis that con-
tains only these important predictor(s) was fitted.
The Hosmer–Lemeshow goodness-of-fit statistic
(Hosmer & Lemeshow, 2000) was used to deter-
mine whether the models provided a good fit for
the data. A significant Hosmer–Lemeshow value
means that the calibration is insufficient, but
large values (p > .05) indicate that the models are
well calibrated and fit the data. Furthermore, recei-
ver operating characteristics (ROC) analyses were
performed on the selection of significant predictor
(s). ROC analysis generates an area under the
curve (AUC) value, which indicates the discrimi-
native power of the predictor.
Results
All experimental malingerers reported on the ques-
tionnaire that they were successful in following our
malingering instructions. In line with this, all par-
ticipants scored below the previously established
cutoff score of 84 on the ASTM (range = 34 to 83),
which indicates that all participants followed the
instructions and adequately feigned (mild) brain
damage according to the present scenario. As a
result, none of the experimental malingerers had
to be removed from the sample.
Group comparisons
The three groups were equivalent for age, sex,
and education level (all p > .08), but significant
differences were found for verbal intelligence
level (DART IQ), F(2, 149) = 4.33, p < .05, ηp
2
= .06. Bonferroni-corrected post hoc analyses
revealed that the patients and healthy controls
did not differ significantly (p = .05), whereas
the patients revealed lower verbal intelligence
level than the experimental malingerers (p =
.03). Correlation analyses revealed that there
were low correlations between DART IQ and
the WMS–IV–NL subtest scores (Pearson pro-
duct–moment correlation coefficients ranging
from –.02 to .34), therefore, no covariates were
included in the analyses.
The MANOVA with group (experimental mal-
ingerers, patients, and healthy controls) as
between-subjects factor and 15 WMS–IV–NL subt-
est scores as dependent variables revealed an
overall main effect for group, F(30, 266) = 5.67,
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p < .001, ηp
2 = .39. Moreover, the Kruskall–Wallis
analyses revealed significant main effects of group
for the WMS–IV–NL BCSE and subtest recogni-
tion scores (all p < .001). Bonferroni-corrected post
hoc tests revealed that patients performed worse
than healthy controls on all WMS–IV–NL scores,
except for the VR II Copy task. Moreover, the
experimental malingerers performed worse than
healthy controls on all WMS–IV–NL scores, except
for the process-score DE I Content; and they per-
formed worse than the patients on LM I, LM II,
VR I, SA, SSP, BCSE, and three of the four recog-
nition tasks (LM-Rec, VPA-Rec, and VR-Rec). The
average WMS–IV–NL subtest, BCSE, recognition,
and process scores for the experimental malin-
gerers, patients, and healthy controls are presented
in Table 2.
Classification accuracy statistics
A logistic regression model was fitted to deter-
mine which of the WMS–IV–NL tasks best
discriminated between patients and experimen-
tal malingerers. Given our a priori hypothesis,
the WMS–IV–NL visual working memory subt-
ests (SA and SSP) and recognition tasks (LM-
Rec, VPA-Rec, DE-Rec, and VR-Rec) were
entered as independent variables into the initial
model. A test of the model with these six vari-
ables against a constant-only model was statis-
tically significant, χ2(6) = 45.78, p < .001,
indicating that this combination of variables
was able to distinguish between patients and
experimental malingerers. Moreover, the value
of the Hosmer–Lemeshow goodness-of-fit sta-
tistic was 4.11, and the corresponding p-value
was .85, which indicated that this model was
well calibrated. The model as a whole explained
between 36.2% (Cox and Snell R square) and
48.2% (Nagelkerke R squared) of the variance
and correctly classified 78.4% of cases. As
reported by the Wald criterion, only the SA
subtest explained a significant amount of varia-
tion (p < .001), recording an odds ratios of 0.60.
Table 2. Mean scores and standard deviations of the WMS–IV–NL indexes and subtests for experimental malingerers,
mixed-etiology patients, and healthy controls.
Mal vs.
controls
Patients vs.
controls
WMS–IV–NL subtest scores
Experimental
malingerers Mean (SD)
Mixed-etiology
patients Mean (SD)
Controls
Mean (SD) F p ηp
2 ηp
2
LM I 5.9 (2.7)a 8.0 (2.8)a 10.3 (3.4)a 27.14 <.001 .34 .13
LM II 5.2 (2.4)a 7.4 (2.8)a 10.1 (3.1)a 39.18 <.001 .44 .17
VPA I 7.1 (1.9)a 7.3 (3.5)b 9.6 (3.4)a,b 11.04 <.001 .18 .11
VPA II 6.3 (2.3)a 7.3 (3.6)b 9.7 (3.6)a,b 15.25 <.001 .25 .10
VPA II Word Recall 6.3 (2.1)a 7.2 (3.6)b 9.9 (3.3)a,b 18.90 <.001 .30 .14
DE I 7.6 (2.7)a 8.0 (3.3)b 10.0 (3.6)a,b 8.18 <.001 .13 .08
DE I Content 8.3 (2.7) 8.2 (3.4)a 9.8 (3.4)a 4.24 .016 .06 .06
DE I Spatial 7.9 (2.7)a 8.5 (3.0)b 10.3 (3.4)a,b 8.45 <.001 .14 .07
DE II 8.1 (2.9)a 8.1 (2.9)b 10.7 (3.2)a,b 13.58 <.001 .16 .16
DE II Content 8.4 (2.9)a 8.0 (2.7)b 9.9 (2.4)a,b 6.94 .001 .07 .12
DE II Spatial 8.9 (2.6)a 8.5 (2.3)b 10.6 (3.4)a,b 8.15 <.001 .07 .12
VR I 5.8 (2.9)a 8.0 (3.7)a 10.5 (3.0)a 27.62 <.001 .40 .13
VR II 6.1 (2.7)a 7.3 (3.1)b 10.3 (3.5)a,b 23.45 <.001 .31 .17
SA 4.0 (2.3)a 8.0 (3.2)a 10.5 (2.8)a 67.29 <.001 .61 .14
SSP 5.2 (3.1)a 7.6 (3.3)a 10.6 (2.9)a 37.60 <.001 .45 .19
WMS–IV–NL BCSE score χ2 p r r
BCSE total score (max = 58) 35.1 (12.8)a 48.9 (9.3)a 53.9 (6.3)a 53.85 <.001 .67 .26
WMS–IV–NL recognition scores χ2 p r r
LM-Rec (max = 30) 20.5 (3.6)a 22.9 (3.7)a 25.5 (2.5)a 45.37 <.001 .66 .38
VPA-Rec (max = 40) 32.0 (5.2)a 35.3 (5.8)a 38.8 (1.9)a 56.98 <.001 .76 .38
DE-Rec (max = 24) 13.5 (3.1)a 14.6 (3.0)b 16.6 (3.1)a,b 21.00 <.001 .75 .43
VR-Rec (max = 7) 3.5 (1.9)a 5.2 (1.7)a 6.5 (0.8)a 61.11 <.001 .45 .29
WMS–IV–NL process score χ2 p r r
VR Copy (max = 43) 40.3 (4.6)a 41.9 (2.1) 42.4 (1.1)a 10.24 .006 .31 .09
Note. WMS–IV–NL = Wechsler Memory Scale–Fourth Edition, Dutch version; Mal = experimental malingerers; LM = Logical Memory; VPA = Verbal
Paired Associates; DE = Designs; VR = Visual Reproduction; SA = Spatial Addition; SSP = Symbol Span; Rec = Recognition; BCSE = Brief
Cognitive Status Exam.The WMS–IV–NL subtest scores are presented in age–adjusted scaled scores (M = 10, SD = 3).
Groups with the same notation (a, b, c) differ significantly (Bonferroni-corrected p < .05).
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Next, a univariate logistic regression model that
contained the stand-alone SA subtest was fitted.
This model was performed to determine whether
the SA subtest alone revealed a similar model
classification. A test of the model with this variable
against a constant-only model was statistically sig-
nificant, χ2(1) = 44.30, p < .001, indicating that the
SA subtest was able to distinguish between patients
and experimental malingerers. Moreover, the value
of the Hosmer–Lemeshow goodness-of-fit statistic
was 1.58, and the corresponding p-value was .99,
which indicated that this model was well cali-
brated. The SA explained between 34.7% (Cox
and Snell R square) and 46.3% (Nagelkerke R
squared) of the variance and correctly classified
76.9% of cases. The odds ratio was 0.58, which
indicates that for every additional subtest scaled
score point on the subtest SA, respondents were
0.58 times less likely to malinger. The regression
coefficients for both models are presented in
Table 3.
Predictive performance of the subtest SA was
further examined using a ROC analysis, which
revealed that SA produced a good separation
between the groups as indicated by the AUC of
0.85 (SD = 0.04, p < .001, 95% CI [0.77, 0.92];
Hosmer & Lemeshow, 2000). Figure 1 shows the
ROC curve for the SA subtest for detecting sub-
optimal performance. As the current study evalu-
ates cutoff scores for measuring performance
validity, high specificity rates are required to mini-
mize false-positive errors—that is, misdiagnosing
an individual with real cognitive deficits (Larrabee
& Berry, 2007). A specificity of 90% is recom-
mended (Axelrod et al., 2006; Babikian et al.,
2006), but this reduces the sensitivity to 52%. In
some contexts, other preassigned values for sensi-
tivity and specificity may be preferred, and, there-
fore, a range of probability cutoff scores for SA and
their associated diagnostic efficiency found in this
sample is presented in Table 4.
Discussion
The present study aimed to examine whether sev-
eral tasks of the WMS–IV–NL could be used as
embedded indicators for the differentiation
between malingerers and patients with mild to
severe acquired brain injuries. Overall, the Spatial
Addition subtest may provide clinically useful
Table 3. Logistic regressions for predictive value of subtests differentiating experimental malingerers from mixed-etiology
patients for the full model and single variable models.
Model Predictor B SE Wald df p Odds ratio 95% CI for odds ratio
Full model WMS–IV–NL subtest scores
SA –0.514 0.134 14.770 1 <.001 0.598 [0.460, 0.777]
SSP 0.041 0.108 0.142 1 .706 1.041 [0.843, 1.287]
WMS–IV–NL recognition scores
LM-Rec –0.010 0.098 0.011 1 .915 0.990 [0.817, 1.199]
VPA-Rec –0.056 0.072 0.590 1 .442 0.946 [0.821, 1.090]
DE-Rec 0.042 0.097 0.188 1 .665 1.043 [0.862, 1.262]
VR-Rec –0.060 0.198 0.091 1 .763 0.942 [0.639, 1.388]
Constant 4.525 2.288 3.912 1 .048 92.284
Single variable SA –0.545 0.108 25.623 1 <.001 0.580 [0.470, 0.716]
Constant 3.092 0.656 22.227 1 <.001 22.014
Note. WMS–IV–NL = Wechsler Memory Scale–Fourth Edition, Dutch version; LM = Logical Memory; VPA = Verbal Paired Associates; DE = Designs;
VR = Visual Reproduction; SA = Spatial Addition; SSP = Symbol Span; Rec = Recognition; CI = confidence interval.
Receiver operating characteristic (ROC) curve for Spatial
Addition subtest scaled score for distinguishing experi-
mental malingerers from mixed-etiology patients. AUC =
area under the curve..
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information for the detection of suboptimal
performance.
Our findings concerning the between-group
comparisons indicated that both the experimental
malingerers and the mixed-etiology patients per-
formed significantly lower than healthy controls
on all WMS–IV–NL scores, which is in line with
previous studies (Carlozzi, Grech, & Tulsky, 2013;
Langeluddecke & Lucas, 2003; Ord et al., 2008).
Furthermore, in comparison with the patients,
experimental malingerers scored significantly
worse on the optional cognitive screener (BCSE),
two auditory verbal memory subtests (LM I and
LM II), one visual memory subtest (VR I), both
visual working memory subtests (SA and SSP), and
three of the four recognition tasks (LM-Rec, VPA-
Rec, and VR-Rec). These results are in agreement
with the notion that malingerers have a tendency
to overestimate the magnitude of cognitive deficits
arising from brain injury and, as a result, show
even poorer performances than patients on pre-
vious editions of the WMS (Langeluddecke &
Lucas, 2003; Rogers, 2007; Schwartz, Gramling,
Kerr, & Morin, 1998).
Since differences in group means of overall per-
formance reveal little information about the test’s
ability to detect suboptimal performance, the clas-
sification accuracy statistics are noteworthy. In our
first logistic regression analysis, the visual working
memory subtests (SA and SSP) and recognition
tasks (LM-Rec, VPA-Rec, DE-Rec, and VR-Rec)
were found to discriminate 78.4% of cases. Of the
variables entered in the model, only the SA subtest
differentiated significantly between patients and
experimental malingerers. These results are not
fully in agreement with some studies that have
showed the use of multiple WMS–IV scores for
the detection of suboptimal performance (J. B.
Miller et al., 2011; Holdnack & Drozdick, 2009;
Young et al., 2012). J. B. Miller and colleagues
(2011) found that four of the five WMS–IV ACS
scores (i.e., Word Choice Test, Digit Span, VPA-
Rec, and VR-Rec) performed well in discriminat-
ing between moderate to severe TBI patients and
coached experimental malingerers. This study by J.
B. Miller et al. (2011) also included the newly
developed Word Choice Test as part of the
optional Advanced Clinical Solutions package for
the WMS–IV, which is not available in the
Netherlands, which may partly explain the discre-
pancy in findings. However, this cannot fully
explain the differences between our and their
study results, as the recognition tasks are equiva-
lent. Moreover, although the study performed by J.
B. Miller et al. (2011) included healthy adults coa-
ched to feign cognitive impairment, which is simi-
lar to our design, these were only compared to
patients with traumatic brain injury. This design
differs from our study that recruited mixed-etiol-
ogy neurological patients. Another study (Young
et al., 2012) found that the SSP subtest differen-
tiated well between adequate and inadequate effort
in a mixed clinical group of veterans, which we did
not find. However, no other WMS–IV subtests
were administered in Young et al. (2012). Finally,
it should be stressed that the authorized Dutch
version of the WMS–IV is equivalent to the ori-
ginally published U.S. version (Hendriks et al.,
2014; Wechsler, 2009), with a similar factor struc-
ture (Bouman et al., 2015). Therefore, it is likely
that our results can be extended to other-language
versions of the WMS–IV.
Our second logistic regression analysis and the
ROC analysis on the stand-alone SA subtest reveal
that this subtest alone has good overall discrimi-
native validity in the detection of malingering with
an AUC value of 0.85. This result is comparable to
the AUCs reported for the WMS–IV Word Choice
Test and WMS–IV SSP subtest (i.e., AUC values of
0.84 and 0.75, respectively: J. B. Miller et al., 2011;
Young et al., 2012), but lower than the AUC value
of 0.95 that was found for the WMS–IV ACS
package (including the WMS–IV recognition
tasks, the Word Choice Test and reliable digit
span: J. B. Miller et al., 2011). Furthermore, the
SA subtest has a sensitivity of 52% at a specificity
of 93%. Thus, when the performance on SA results
in a score of 4 or less, there is a substantial risk of
approximately 50% false negatives (i.e., missing
feigned cognitive impairment) but, more impor-
tantly, there is only a risk of approximately 10%
Table 4. Sensitivity and specificity for different Spatial
Addition subtest scaled score cutoff scores.
Cutoff value Sensitivity (%) Specificity (%)
<2 10 100
<3 30 96
<4 52 93
<5 62 89
<6 74 80
<7 80 70
<8 94 50
<9 96 43
<10 98 26
<11 100 17
Note. Extreme values for the curve were omitted to increase
readability.
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false positives (i.e., misclassifying an individual
with real cognitive deficits). These results are com-
parable to the previously reported average sensitiv-
ity of .53 and specificity of .91 for 5 embedded
indicators on standard neuropsychological and
psychological tests (Larrabee, 2003). Moreover,
the sensitivity is somewhat higher than the sensi-
tivity of 26% that was found at a specificity of 93%
for the SSP subtest reported by Young et al. (2012).
Notably, the experimental malingerers were coa-
ched about what symptoms to expect, as well as
being warned about performance validity tests.
These processes can affect malingering performance
and may have dropped the identification accuracy
of the embedded indicators in the WMS–IV exam-
ined in this study (Jelicic et al., 2007; Schenk &
Sullivan, 2010). However, it is likely that the experi-
mental malingerers adequately feigned (mild) brain
damage, as they all scored below the cutoff score of
84 on the ASTM (range = 34 to 83). Moreover, with
a cutoff score of ≤83 the ASTM has a specificity of
95%, so less than 5% of the neurologically impaired
patients in the validation study performed that low
(Schmand et al., 2005).
Several limitations of this study need to be
addressed. First, in comparison to the study by J. B.
Miller et al. (2011), we included a sample of analogue
malingerers. Although analogue study designs have
been recommended (Bush et al., 2005; Heilbronner
et al., 2009), this design has sometimes been criti-
cized for external validity concerns as it remains
unclear whether the experimental malingering per-
formance of these healthy controls is comparable to
real-world malingering (cf. Haines & Norris, 1995;
Larrabee, 2007; Rogers, 2007; Suhr & Gunstad, 2000;
Vickery et al., 2004). Further research is warranted to
replicate these findings in clinical studies with sus-
pected, real-world malingerers.
One could also argue that it is a limitation that
the clinical sample is heterogeneous—that is, con-
sisting of patients having different neurological dis-
orders. However, we purposely included a
heterogeneous sample, as we wanted to enhance
the external validity of our findings relevant for use
in a mixed-etiology patient group. In future, it
would be interesting to examine the applicability of
the WMS–IV, and in particular the SA subtest, in
the identification of malingering in specific neuro-
logical (or psychiatric) disorders, comparing, for
instance, mildly, moderately, and severely cogni-
tively impaired patients, as well as different sub-
groups (e.g., different types of stroke or different
subtypes of MS), as well as other settings.
Furthermore, only patients who did not show evi-
dence for suboptimal performance (based on perfor-
mance validity testing or expert opinion) were
referred to our study based on the inclusion criteria.
As a result, our patient sample did not complete the
same PVT, as performance validity testing was done
as part of the diagnostic work-up of the individual
clinics using different, yet widely used PVTs.
In conclusion, findings from the current study
show that theWMS–IV–NL visual working memory
subtest Spatial Addition might be a valid embedded
indicator for the detection of suboptimal perfor-
mance. However, it should be stressed that the
test’s sensitivity is lower than its specificity, making
it important to not base the detection of suboptimal
effort on a single test; rather the Spatial Addition
subtest might have added value in clinical practice
when used in combination with other measures for
the detection of suboptimal performance.
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Appendix
Questionnaires for the experimental malin-
gerers before and after testing
Semistructured questions before testing
(translated)
(1) Have you experienced any differences in your behaviour or
well-being since the accident? What kind of differences have
you experienced? When did the (particular complaint) start?
Has it worsened over time? How does it interfere with your
everyday life?
Questions to be answered after testing
(translated)
(1) How did you try to simulate brain damage?
(2) How successful do you think you were at simulating brain
damage?
Very unsuccessful–very successful
1 2 3 4 5
(3) Did you search for extra information on brain damage in
order to prepare for your role?
Yes No
(4) If YES: how did you search for extra information?
— I looked up information online.
— I looked up information in books.
— I asked a friend/acquaintance for help.
— Other:___________________________________
(5) If YES: what information did you use to help you simulate
brain damage?
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